Additionally, studies have demonstrated that NDR1/FBXO11 enhances phosphorylation-mediated ubiquitination of β-catenin, thereby inhibiting metastasis in prostate cancer (Xuan et al., 2024). This evidence concerns the gene FBXO11 and prostate carcinoma.